Control Bionics (ASX:CBL) Dividends Paid: A$0.00 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Control Bionics Dividends Paid?

Control Bionics ASX:CBL -3.23% Dividends Paid is A$0.00 Mil as of Dec. 2025. The stock has 4 warning signs investors should review.

Control Bionics's Dividends Paid for the six months ended in Dec. 2025 was A$0.00 Mil.

Control Bionics's Dividends Paid for the trailing twelve months (TTM) ended in Dec. 2025 was A$0.00 Mil.

Control Bionics Dividends Paid Related Terms

Control Bionics Dividends Paid Historical Data

* Premium members only.

The historical data trend for Control Bionics's Dividends Paid can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Control Bionics Dividends Paid Chart

Control Bionics Annual Data
Trend Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Dividends Paid
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Control Bionics Semi-Annual Data
Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Dividends Paid Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Control Bionics Dividends Paid Calculation

A company's cash flow from operations for a time period can be determined using either the direct or indirect method. The indirect method modifies the operating section from accrual accounting to a cash basis by taking the net income generated in a period and adding or subtracting changes in the asset and liability accounts to determine the implied cash flow. However, the direct method uses actual cash inflows and outflows from the company's operations directly. Dividends Paid represents dividend paid to the investors in the direct cash flow method.

Dividends Paid for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Dividends Paid →
What does a Dividends Paid of A$0.00 Mil mean?
Control Bionics (ASX:CBL) has a Dividends Paid of A$0.00 Mil as of Dec. 2025. Dividends Paid represents dividend paid to the investors in direct cash flow method. View historical data for Control Bionics and its competitors.
Is Control Bionics' Dividends Paid too high?
Control Bionics' current Dividends Paid is A$0.00 Mil.
How does Control Bionics' Dividends Paid compare to ABT and SYK?
Control Bionics' Dividends Paid of A$0.00 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividends Paid for a Medical Devices & Instruments company?
A good Dividends Paid depends on the Medical Devices & Instruments industry context. However, Dividends Paid should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividends Paid mean?
A high Dividends Paid can signal that a stock is expensive relative to its fundamentals. Dividends Paid represents dividend paid to the investors in direct cash flow method. View historical data for Control Bionics and its competitors. Control Bionics's current Dividends Paid is A$0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Control Bionics stock overvalued right now?
Based on GuruFocus' analysis, Control Bionics (ASX:CBL) is currently considered Significantly Overvalued. The stock's GF Value™ is A$0.03, compared to a current price of A$0.06 — trading 100% above its estimated fair value. The current Dividends Paid is A$0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividends Paid calculated?
Dividends Paid is calculated from a company's financial statements. For Control Bionics (ASX:CBL), the current Dividends Paid is A$0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Control Bionics Business Description

Address 11-13 Pearson Street, Level 4, Cremorne, VIC, AUS, 3121
Control Bionics Ltd is engaged in the healthcare device business. It is involved in developing, commercializing, and selling assistive communications technology systems within the disability sector. Its core systems include NeuroNode Trilogy and NeuroNode3. These systems allow people with speech and movement difficulties to control a computer for speech generation, electronic communications, entertainment, and external control of other devices. Geographically, it derives a majority of revenue from North America and has its presence in Australia as well.